In a compelling interview with The Regulatory Review , Michelle Mello, a leading scholar in empirical health law, delves into how the intersecting forces of law, artificial intelligence (AI), and the COVID-19 pandemic are reshaping the healthcare landscape. Her insights illuminate the crucial roles
September 9, 2024In the ever-evolving landscape of healthcare, the role of pharmacies has significantly transformed. Traditionally seen primarily as dispensers of medication, today's pharmacies are increasingly integrating diverse health services into their offerings. This shift prompts a crucial question:
September 4, 2024Colorado is making significant strides in redefining mental health care by embracing psychedelic-assisted therapy, following the approval of specific rules and requirements by the state's Department of Revenue. These therapies, expected to be available by 2025, could mark a pivotal shift in
September 3, 2024The Care Quality Commission's (CQC) Single Assessment Framework (SAF) has ushered in notable changes to the regulation of health and social care services in England. Introduced with the aim of promoting consistency and clarity, the SAF consolidates four previously distinct frameworks into a
August 30, 2024In an era marked by escalating cyber threats, the protection of sensitive healthcare data has never been more critical, especially given the rise in third-party breaches affecting healthcare organizations. Asaf Kochan emphasizes the importance of maintaining continuous visibility into the
August 23, 2024The U.S. Department of Justice has introduced a pivotal rule under the Americans with Disabilities Act (ADA) aimed at significantly increasing the accessibility of medical diagnostic equipment (MDE) across medical facilities run by public entities. Published on August 9, 2024, this regulation takes
August 22, 2024